importance of genetic research in zoo breeding programmes for threatened species: the African dwarf crocodiles (genus Osteolaemus) as a case study von Schmidt, F, Franke, F. A, Shirley, M. H, Vliet, K. A, Villanova, V. L

Volltext

Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer von Jänne, P A, Smith, I, McWalter, G, Mann, H, Dougherty, B, Walker, J, Orr, M C M, Hodgson, D R, Shaw, A T, Pereira, J R, Jeannin, G, Vansteenkiste, J, Barrios, C H, Franke, F A, Crinò, L, Smith, P

Volltext

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer von Peters, Solange, Camidge, D. Ross, Shaw, Alice T, Gadgeel, Shirish, Ahn, Jin S, Kim, Dong-Wan, Ou, Sai-Hong I, Pérol, Maurice, Dziadziuszko, Rafal, Rosell, Rafael, Zeaiter, Ali, Mitry, Emmanuel, Golding, Sophie, Balas, Bogdana, Noe, Johannes, Morcos, Peter N, Mok, Tony

Volltext

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma von Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee

Volltext

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer von Sternberg, Cora N, Fizazi, Karim, Saad, Fred, Shore, Neal D, De Giorgi, Ugo, Penson, David F, Ferreira, Ubirajara, Efstathiou, Eleni, Madziarska, Katarzyna, Kolinsky, Michael P, Cubero, Daniel I. G, Noerby, Bettina, Zohren, Fabian, Lin, Xun, Modelska, Katharina, Sugg, Jennifer, Steinberg, Joyce, Hussain, Maha

Volltext

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer von Fizazi, Karim, Tran, NamPhuong, Fein, Luis, Matsubara, Nobuaki, Rodriguez-Antolin, Alfredo, Alekseev, Boris Y, Özgüroğlu, Mustafa, Ye, Dingwei, Feyerabend, Susan, Protheroe, Andrew, De Porre, Peter, Kheoh, Thian, Park, Youn C, Todd, Mary B, Chi, Kim N

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial von Lordick, Florian, Prof, Kang, Yoon-Koo, Prof, Chung, Hyun-Cheol, Prof, Salman, Pamela, MD, Oh, Sang Cheul, Prof, Bodoky, György, Prof, Kurteva, Galina, MD, Volovat, Constantin, MD, Moiseyenko, Vladimir M, Prof, Gorbunova, Vera, Prof, Park, Joon Oh, MD, Sawaki, Akira, MD, Celik, Ilhan, Prof, Götte, Heiko, PhD, Melezínková, Helena, MD, Moehler, Markus, Prof

Volltext

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer von Baselga, José, Cortés, Javier, Kim, Sung-Bae, Im, Young-Hyuck, Im, Seock-Ah, Hegg, Roberto, Roman, Laslo, Pedrini, José Luiz, Pienkowski, Tadeusz, Knott, Adam, Clark, Emma, Benyunes, Mark C, Ross, Graham, Swain, Sandra M

Volltext

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer von Agnelli, Giancarlo, George, Daniel J, Kakkar, Ajay K, Fisher, William, Lassen, Michael R, Mismetti, Patrick, Mouret, Patrick, Chaudhari, Umesh, Lawson, Francesca, Turpie, Alexander G.G

Volltext

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-... von Saad, Fred, Dr Prof, Fizazi, Karim, Prof, Jinga, Viorel, Prof, Efstathiou, Eleni, MD, Fong, Peter C, MD, Hart, Lowell L, MD, Jones, Robert, MD, McDermott, Raymond, MD, Wirth, Manfred, Prof, Suzuki, Kazuhiro, Prof, MacLean, David B, MD, Wang, Ling, PhD, Akaza, Hideyuki, Prof, Nelson, Joel, Prof, Scher, Howard I, Prof, Dreicer, Robert, Prof, Webb, Iain J, MD, de Wit, Ronald, Prof

Volltext

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial von Parrino, Janie, Popmihajlov, Zoran, Annunziato, Paula W, Fein, L, Singh, M, Morrissey, O, Kuehr, T, Duck, L, De Prijck, B, Serrano, SV, Camargo, JFC, Radinov, A, Minchev, V, Grimard, D, Weiss, K, Diaz-Mitoma, FJ, Torres Ulloa, R, Fardella, P, Gonzalez, P, Gonzalez, ME, Rojas, CA, Paulson, G, Ontaneda, M, Laine, F, Laurichesse, H, Duval, X, Cornely, OA, Zaiss, M, Verbeek, M, Georgoulias, V, Terpos, E, Umanzor, J, Bejarano, S, Gentile, G, Rambaldi, A, Marei, L, Abbadi, A, Kattan, J, Blacklock, H, Tiangco, BJ, Cabanillas, F, Ciuleanu, TE, Cainap, CI, Dvorkin, MV, Litvinov, IV, Goh, YT, Matejkova, M, Reckova, M, Yoon, SS, Duran Martinez, I, Chen, C-Y, Sriuranpong, V, Akan, H, Mullan, SR, Sivarajan, K, Marquez, F, Mullane, MR, Mazurczak, MA, Zenk, D, Robinson, MO, Naqvi, T, Ahmed, M, Badarinath, S, Kendall, SD, Chedid, S, Rafiyath, S, Buechler-Price, J, Sreenivasappa, S, Geller, R, Nieva, J, Wong, BMY, Ibrahim, EN, Oliff, IA, Guter, KA, Rao, SB, Columbie, A, Nualart, MT, Campos, LT, Sharma, S, Ortiz, T, Markowitz, AB, Koo, VS, Murray, C, Gurtler, JS, Ascensao, JL, Santander, JL, Garg, RJ, Lowry, P, Baker, J, Roeland, E, Payne, JE, Betts, RF, Sharp, SA, Congdon, J, Wos, EJ, Hutchins, M, Chowhan, NM, O'Rourke, TJ, Winkler, CF, Duic, JP

Volltext

Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study von Lee, A. Y. Y., Meyer, G., Bauersachs, R., Janas, M. S., Jarner, M. F., Khorana, A. A., Bella Santiago, R., Zarbá, J. J., Andel, J., Borba Reiriz, A., Cesario, F., Azevedo, S., Ferreira Filho, A. F., Franke, F. A., Padilha, S., Rigo, R., Santos Borges, G., Georgiev, G., Champion, P., Kuruvilla, P., Ditl, P., Förster, J., Lubomir, B., El Hassan, R. A., Sabri, S., Elzawawy, A., Ezzat, S. S., Bacchus, L., Niederwieser, D., Ostermann, H., Anagnostopoulos, N., Fountzilas, G., Liapis, C., Atilli, S., Deshmukh, C., Singh, D. P., Gharami, F., Goyal, L., Gupte, S., Mukherjee, K. K., Kumar, K., Mehta, A., Pawar, S., Brenner, B., Kolin, M., Enrico, B., Visani, G., Awidi, A., Miscuks, J., Makarem, J., Alvarez Ordorica, O., Calderillo Ruiz, G., de la Concha Ureta, J. H., Pantigoso, W. S. R., Philco, M., Pineda, A. R., Queszada, E. A. V., Ciuleanu, T.‐E., Ligia, C. C., Lungulescu, D., Manolescu, I. G., Burov, Y., Svistov, D., Algahtani, F., Jovanovic, D., Perin, B., Tomasic, L., Chovanec, J., Herman, O., Kissova, V., Špánik, S., Szentivanyi, M., Gallardo, E., Jiménez, D., Sanchez, A., Engelbrecht, J., Patel, M., Rapoport, B., Oh, D., Kim, H., Kim, H.‐K., Kim, H. J., Chung, J., Park, K. U., Shin, S.‐W., Yoon, S‐S., Chiu, C.‐F., Chang, C.‐S., Liu, J.‐H., Rau, K.‐M., Chittima, S., Nonglak, K., Pantep, A., Pramook, M., Thanakrit, S., Patrapim, S., Sumitra, T., Udomluck, C., Kobza, I., Prasol, V.

Volltext

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients von Smith, I.E., Pierga, J.-Y., Biganzoli, L., Cortés-Funes, H., Thomssen, C., Pivot, X., Fabi, A., Xu, B., Stroyakovskiy, D., Franke, F.A., Kaufman, B., Mainwaring, P., Pienkowski, T., De Valk, B., Kwong, A., González-Trujillo, J.L., Koza, I., Petrakova, K., Pereira, D., Pritchard, K.I.

Volltext

The importance of genetic research in zoo breeding programmes for threatened species: the A frican dwarf crocodiles (genus O steolaemus ) as a case study von Schmidt, F., Franke, F. A., Shirley, M. H., Vliet, K. A., Villanova, V. L.

Volltext

Biomarker analyses from an open-label study of erlotinib in advanced non-small-cell lung cancer (NSCLC) von van Zandwijk, N., Su, W., Rooneem, R., Mehi|Dc, B., Franke, F. A.

Volltext

First-line bevacizumab (BEV) and chemotherapy (CT) for metastatic colorectal cancer (mCRC): Results from a developing nation von Franke, F. A., Azevedo, S. J., Gampel, O., Guimarães, J. Q., Schaum, M. R., Murad, A., Coutinho, A. K., Oliveira, J. A., Matos Neto, J. N., França, M. L.

Volltext

Tolerability of pemetrexed versus placebo as a maintenance therapy in advanced non-small cell lung cancer: Evidence from a large randomized study von Zielinski, C. C., Yang, S., Santoro, A., Ramlau, R., Liepa, A. M., Peterson, P., Brodowicz, T., Madhavan, J., Franke, F. A., Cucevic, B.

Volltext

MO19391: An open-label safety study of bevacizumab plus taxane-based therapy as first-line treatment of patients with locally recurrent (LR) or metastatic breast cancer (MBC) von Pierga, J., Pritchard, K. I., Cortes-Funes, H., Biganzoli, L., Thomssen, C., Franke, F. A., Smith, I. E., Bogdanova, N., Stroyakovskiy, D.

Volltext

Quality of life (QoL) improvements in 1,464 patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X) in Brazil: Updated results from a large pt cohort, includi... von Oliveira, C., Ribeiro, R., Segalla, J. G., Tessaro, S., Cabral, S., Franke, F. A., De Paula, U., Moura, G. L., Perdicaris, M. R., Garicochea, B.

Volltext